Literature DB >> 15920134

Angiotensin receptor blockers and myocardial infarction: analysis of evidence is incomplete and inaccurate.

John McMurray.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920134      PMCID: PMC558105          DOI: 10.1136/bmj.330.7502.1269

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Angiotensin receptor blockers and myocardial infarction.

Authors:  Subodh Verma; Marty Strauss
Journal:  BMJ       Date:  2004-11-27

2.  Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.

Authors:  Tomas Berl; Lawrence G Hunsicker; Julia B Lewis; Marc A Pfeffer; Jerome G Porush; Jean-Lucien Rouleau; Paul L Drury; Enric Esmatjes; Donald Hricik; Chirag R Parikh; Itamar Raz; Philippe Vanhille; Thomas B Wiegmann; Bernard M Wolfe; Francesco Locatelli; Samuel Z Goldhaber; Edmund J Lewis
Journal:  Ann Intern Med       Date:  2003-04-01       Impact factor: 25.391

3.  Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.

Authors:  Kenneth Dickstein; John Kjekshus
Journal:  Lancet       Date:  2002-09-07       Impact factor: 79.321

4.  Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.

Authors:  Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren; Salim Yusuf; Stuart Pocock
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

5.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Authors:  Marc A Pfeffer; John J V McMurray; Eric J Velazquez; Jean-Lucien Rouleau; Lars Køber; Aldo P Maggioni; Scott D Solomon; Karl Swedberg; Frans Van de Werf; Harvey White; Jeffrey D Leimberger; Marc Henis; Susan Edwards; Steven Zelenkofske; Mary Ann Sellers; Robert M Califf
Journal:  N Engl J Med       Date:  2003-11-10       Impact factor: 91.245

  5 in total
  2 in total

Review 1.  A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors.

Authors:  Helmy M Siragy
Journal:  Vasc Health Risk Manag       Date:  2011-05-19

Review 2.  Valsartan in the treatment of heart attack survivors.

Authors:  Bodh I Jugdutt
Journal:  Vasc Health Risk Manag       Date:  2006
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.